I n c h i l d r e n w i t h i s o l a t e d GH d e f l c l e n c y , n o t t r e a t e d e a r l y w i t h hGH, f i n a l h e i g h t may b e c o m p r o m i s e d b y p u b e r t y i n i t i a t i o n . P r e v i o u s a t t e m p t s t o l n h i b i t p u b e r t a l d e v e l o p m e n t i n s u c h s u b j e c t s b y c y p r o t e r o n e a c e t a t e f a i l e d t o i m p r o v e f i n a l h e i g h t . W e a t t e m p t e d t o i n h i b i t p u b e r t y w i t h LiIRH a n a l o g i n t w o a d o l e s c e n t s w i t h i s o l a t e d GH d e f i c i e n c y , a g e d 1 4 . 5 y e a r s ( c a s e I ) a n d 1 2 y e a r s ( c a s e 1 1 ) r e s p e c t i v e l y , i n o r d e r t o p r o l o n g t h e g r o w t h p e r i o d a n d p o s s i b l y i m p r o v e f i n a l h e i g h t .
One r e c e l v e d LHRH a n a l o g b y n a s a l s p r a y a n d t h e o t h e r IM m o n t h l y i n j e c t i o n ( T R~~ m i c r o c a p s u l c l . hGH w a s g i v e n IM, 41U 3 t i m e s w e e k l y .
T h e m o s t p e r t i n e n t d a t a a r e l i s t e d b e l o w :
c a s e I ( n a s a l ) c a s e I1 ( I M ) D u r a t i o n o f Rx ( m o n t h s ) 15
2
A h e i g h t (cm) G 1 4 1 b o n e a g e ( m o n t h s ) 4 1 2 T e s t e s ( m l ) b e f o r e / a f t e r 1 5 / 9 1 5 / 9 LH p e a k (mIU/ml) p o s t L H R H / a f t e r 3 . 8 3 . 4 T e s t o s t e r o n e n g / d l b c f o r e / a f t e r 3 0 0 / 4 0 2 0 0 / 7 0 A l t h o u g h it is t o o e a r l y t o p r e d i c t t h e e f f i c a c y o f s u c h i n t e rv e n t i o n , a r a t i o o f n~t . a g e t o n B . a g e g r e a t e r t h a n 2 s u g g e s t s t h a t i m p r o v e m e n t i n f i n a l h e i g h t m i g h t b e a c h i e v e d . T h i s h o w e v e r r e q u i r e s confirmation b y l o n g e r f o l l o w -u p p e r i o d .
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The Middlest-x Hospital, London lil. EmLC1 OF CROW1 IIORMONE (CII) ANTIBOUlES O N TIIE Cll CONCENTllATIONS OBTAINED AFTER ADI.IiNISTRATION OF IIOSYHTliETIC Ul TO CIIILIIREN L i t t l e i s known of the e f i e c t o t Cll .intibodies (GIVIBS) on t h e b i o a v a i l a b i l i t y of administered Cll. W e have developed methods i o r measuring f r e e Ctl concentrations (FGII), using n polyethylene glycol (I'CG) eatractioil, and totill Cll concentrnLions (TCII), by acid u s s o c i a t i o~l 01 the CII-GIIARS complex followed by PEG p r e c i p i t a t i o n of antibody. Standard plasma Cll concenLrntions (PGH) were measured by immunoradiometric dbsay.
Correlation c o e f f i c i e n t of 0.98 wcre found between FGtl, TCil and PC11 i n 24 hour p r u i i l e s from t.211 children.
GllhRS have been observed in 48% of 427 children t r e a t e d with "armus prepdr.itions of b i o s y n t h e t i c C.H. TClI, FCll 2nd PLll concentrations were measurrd in samples trom 1 2 6 of these children. In 31 who had developed GHABS, TGH and PGll conccntratlons wcre markedly clev.ited comparcd t o FGli concantmtions. In the remaining children withoul CIIABS, t h e r e were no d i f f e r e n c e s .
M. I l o z z o l a , A. M o r e t t a * , A. V a l t o r t a " , I?. M a c c a r l o ' , D. M o n t a g n a * , M. B o g h e n * , G.R. D u r g i o r 80 P o l~c l i n i c o S a n M a t t e o , I ' a v l a , I t a l y P i e r r c l , M~l a n o , I t a l y
MODUI.ATXNG EFFECT OF GROWTI1 IIORMONE (GH) ON "IN VITilO'
LYMl'liOPlZOLII~ERATION (1.1' ) .
i n o r d e r t o l n v e s t l g a t e t h e a b l l l t y o f GI1 a n d Gll-releasing h o y rnone (GII-RH) t o n~o d u l a t e LP " i n v i t r o " , p c r l p h e r a l b l o o d l y m p h o c y -t e s (PBL) f r o m h e a l t h y a d u l t s w e r e stimulated w i t h I'llA i n t h e p r e -s e r i c e o f increasing c o n c e n t r a t i o n s o f b l o s y n t h e t i c GI1 ( S o n i a t o n o r m )
( 0 . 4 2 5~1 0~-5 0 1 . 5~1 0~ n g / m l ) a n d o f GII-RH ( 1 -2 9 , K a b l -V i t r u m ) (O.OOC -5 0 u g / m
l ) . T h e r e s u l t s o b t a l n e d s h o w t h a t l o w d o s e s o f GH a n d
GII-RL i n c r e a s e LP " i n v i t r o " , w h i l e h l g h c o n c e n t r a t l o n s o f t h e hoy 3 mories ( G l l : 8 . 5~1 0 n g / m l ; GII-HII:O.O48 u g / m l ) I n d u c e a p r o g r e s s i v e / d e c r e a s e o f PHA-induced LP. No d i f f e r e n c e s i n c e l l viability w e r e o b s e r v e d w l t h arid i v l t h o u t GI1 a n d Gli-RIi a n d c o~n p a r a b l e p e r c e n t a g e s o f TAC' c e l l s a n d o f 11,-2 p r o d u c t l o r 1 w e r e f o u n d i n a l l conditions t e s t e d . N e v e r t h e l e s s , w h e n e x o g e n o u s r e c o m b i n a n t IL-2 w a s a d d e d t o
P l i A -i n d u c e d PBL c u l t u r e w i t h h i g h d o s e s o f GI1 o r GII-RH, a r e c o n s t i t u t i o n o f LP vias o b s e r v e d . F u r t h e r e x p e r i m e n t s seer11 t o e x c l u d e t h e p r e s e n c e of T -s u p p r e s s o r l y m p h o c y t e i n d u c t i o n b y GH a n d GI(-RII. Thc p r e s e n t r e s u l t s s u g g e s t t h e h y p o t h e s~s t h a t h r g h d o s e s o f Gli a n d
Gll-Rli may i n t e r f e r e w i t h t h e b i n d i n g b e t w e e n I L -2 a n d ~t s mernbran c r e c e l j t o r o n activated lymphocytes. S t t r e a t m e n t ( G r . A ) , t h e n f o l l o w i n g t h e 1 w e e k ( G r .
B ) , t h r n a g a l n r d t h t h a t t h e 3 -Cjth m o n t h ( G r . C ) , a n d f i n a l l y a t t h e 9 -1 2 m o n t h o f t h e r a p y . C e l l -r n c d l a t c d i m m u n i t y w a s a s s e s s e d b y q u a n t i t l t a t l o n o f T l y m p h o c y t e s u b p o p u l a t i o n s (T t o t a l , h e l p e r a n d s u p p r e s s o r c e l l s ) u s i n g m o n n p l o n a l a n t l b o d l e s (OKT3, OKT4, OKT8). No v a r l at i o n s i n s e r u m l m r n u n o g l o b u l~n l e v e l s w e r e o b s e r v e d t h r o u g h t t r e a t m e n t p e r i o d . P r e t r c a t m c n t OKT3, OK'S4, OKT8 v a l u e s ( G r . A) w e r e
w l t h l n t h e n o r n~a l r a n n e a n d d i d n o t c h a n g e a f t e r t h e I S t week o f --CII p r o f i l e s were obtained over 12-24 hours a f t e r injectiorl of GI1 from 5 GI1 t h e r a p y ( G r . U ) . H o w e v e r , following 3-6 m o n t h GH t r e a t m e n t ( G r . children who developed GllABS which wcrc s i g n i f i c a n t l y d i f f e r e n t from t h e p r o f i l e s observed in 5 children without GHAIIS. The GI1 peak was observed a t 6 C ) , OKT3 s l g n l f i c a n t l y increased ( 7 0 . 6 1 t l . 
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A IIADIOIMMUNOPREClI'ITATION ASSAY (RIPA) 1,DR ANTIBODIES TO CROWTll IIORMONE (611) A h~g h l y s e n s i t i v e r a d i o i c n m u n o p r~c i p i t a t i o~l assay f o r antibodies t o pruwth hormone was developed f o r monitoring children t r e a t e d with c u r r e n t l y a v a i l a b l e 22K methionyl and natural sequence CII preparations. Serum (50 u l ) was inc~b~3rt.d f o r 24 h With 125-Iodine-labelled 22K natural sequence Git (76 ~C i l u g , 20,000 cpnl per tube) in b u f f e r (200 "1): 0.04 moll1 sodium phosphate and 0.1 moll1 sodium c h l o r i d e , pll 7.4. Antibody-bound GI1 was p r e c i p i t a t e d with polyethylene glycol 150 g l l .
me d i s t r i b u t i o n of binding by control sera was skewed and was normalized by l a g transformation. Binding of >5.2% was cor~sidered p o s i t i v e I99% confidencel. S p e c i f i c i t y of bindilig was confirmed by incubation with ""labelled GI!. Four hundred and twenty-seven c h~l d r e n were screened: 81 were c o n t r o l s , 346 had been t r e a t e d with G H for 3 inanths or more. I n p a t j e n t s t r e a t e d with p i t u i t a r y and mcthionyl GII, 13/77 had arttibodies (median binding; range) (6.9; 5.4 -24.6%); with p i t u i t a r y GI1 35/40 (7.3; 5.4 -27.2%); with n a t u r a l secquencc Gll 6/67 (15.1; 6.7 -25.0%), and with methionyl Gli only 711162 (23.1; 5.7 -57.1%) Of children who had receivpd cranio-spinal i r r a d i a t i o n 10133 had very high t i t r e s (45.7; 28.3 -57.1%), suggesting an a l t e r e d immunological response i n t h i s group. lie have v a l i d a t e d a s p e c i f i c and s e n s i t i v e RIFA f o r the d e t e c t i o n of Cll antibodies i n serum.
--m o n t h o f t h e r a p y ( G r . D l , t h e p e r c e n t a g e o f T c e l l s w a s n o t s i g n i f ' i c a n t l y different f r o m p r e t r e a t~i i e n l v a l u e s . O u r d a l . ;~ s u g g e s t s ome r e l a t l o n s h l p b e t w e e n GH a n d t h y m~c -d e p e n d e n t lmrnune function. No o t h e r h o r m o n a l d e f i c i t s w e r e p r e s e n t a t t h e s t a r L o f G R -t r e a t m e n t . D u r i n g Lhe f i r s t y e a r o n Gtf-LreatnienL a c a t c h u p i n g r o w t h velac l t y w a s s e e n w i t h a n i n c r e m e n t f r o m mean 3 c m / y e a r L O 8 , 5 cni/ y e a r ( m e a n -2,2 SDS L O + 3 , 5 SIIS). 1 ) u r i r i g tlic. s e c o n d y e a r g r i~* , t h v e l o c i L y d e c r e a s e d s o m c u h a t h u~ s t i l l r e m a i n e d a t a n i n c r c ; i s c d s p e e d c o r r c s p o n d i n g Lo +1,9 SDS. T h e a c t u a l inc.,l~i h e i g h t o f L l~e c h i l d r e n l n c r e a s c r l i r o~i i -1,6 SD t o -0 , 4 SD a f t e r ~w o y e a r s t r e a tmen t .
'I'l~c l n c r e n l e n t i n g r o w l l i i n t h e s e c h i l d r e n c o r r e s p o n i l s w e l l v i l l i L h a t s e e n I n p a r t i a l l y C 1 1 -d e f i c i e n t c h i l d r c n o f o t h e r e t i o l o g y a n d i s s o n~e i v h a l l e s s L11;ln c a t c h i~p g r o w t h s e e n i n ~o t a l l y (ill-dcf i c i e l i t c h i l d r e n . O u r r e s u l~s a r e h o u c v c r b e t t e r t h a n p~e v i o u s l y r c p o r t e d f o r i r r a i l i a t e d c h~l d r e~i . T h i s r n i g h i l~e d u e L O t h e h i g h e r d o s e a n d f r e q u e r i c y o f ( ; I t -a d m i n i s~r a~i o n i r i t h i s s~u i l y .
